NEWS
CONTENTS
CONTACT

HARAKENZO
WORLD PATENT & TRADEMARK


OSAKA
HEAD OFFICE

DAIWA MINAMIMORIMACHI BLDG.,
2-6, 2-CHOME-KITA, TENJINBASHI,
KITA-KU,OSAKA 530-0041 JAPAN
TEL:+81-6-6351-4384
(Main Number)
FAX:+81-6-6351-5664
(Main Number)
E-Mail:

TOKYO
HEAD OFFICE

WORLD TRADE CENTER BLDG. 21F,
2-4-1, HAMAMATSU- CHO, MINATO-KU,
TOKYO 105-6121,JAPAN
TEL:+81-3-3433-5810
(Main Number)
FAX:+81-3-3433-5281
(Main Number)
E-Mail:


HIROSHIMA
OFFICE

NOMURA REAL ESTATE HIROSHIMA BLDG. 4 F, 2-23 TATEMACHI, NAKA-KU, HIROSHIMA CITY, HIROSHIMA 730-0032, JAPAN
TEL:+81-82-545-3680
(Main Number)
FAX:+81-82-243-4130
(Main Number)
E-Mail:

To be opened
on March.1.2018

NAGOYA
OFFICE

GLOBAL GATE 9F, 4-60-12 HIRAIKE-CHO, NAKAMURA-KU, NAGOYA-SHI, AICHI 453-6109, JAPAN
TEL:+81-52-589-2581
(Main Number)
FAX:+81-52-589-2582
(Main Number)
E-Mail:


In the background of the HARAKENZO trademark is a global map wherein countries/regions are sized according to the number of patents registered there in 1991.

Privacy policy


NEWS
IP News index

South Africa And India Request Suspension of COVID-19 Vaccine Patents; No Agreement Reached Between Wealthy And Developing Nations

Wealthy nations affiliated to the World Trade Organization (WTO) rejected, on March 10, 2021, a request by more than 80 developing nations that the COVID-19 vaccine patents should be suspended for the purpose of expanding production of the COVID-19 vaccine for impoverished nations.

South Africa and India proposed suspending rules of the WTO's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS agreement), which may encourage drug companies such as generic drug makers to expand production of the vaccine, and gained the support from developing nations. However, western nations including Britain, Switzerland, member nations of the European Union, and the United States, which are home to big pharmaceutical industries, opposed the proposal.

The western nations insist that the research and innovation are promoted by protecting the intellectual property rights and suspending such rights never leads to rapid expansion of supply of the vaccine.

https://www.newsweekjapan.jp/stories/business/2021/03/post-95804.php













































IP News index
PAGE TOP
Intellelution.com